Biliary Atresia Therapeutics Market Opportunities Are Emerging Beyond Traditional Growth Areas
Biliary Atresia Therapeutics market size was valued at $1.11 billion in 2026, projected to reach $1.53 billion by 2030 at an 8.5% CAGR. Key players: Ipsen, Mirum Pharmaceuticals, CANbridge Pharmaceuticals

